ADVISORY/Leukemia Society of America Announces Press Conference.--(BW HealthWire)-- MEDIA ADVISORY: LIVE ON THE INTERNET: IMMUNOTHERAPY OF LEUKEMIA & LYMPHOMA PRESS CONFERENCE AT WWW WWW or W3: see World Wide Web. (World Wide Web) The common host name for a Web server. The "www-dot" prefix on Web addresses is widely used to provide a recognizable way of identifying a Web site. .BROADCAST.COM LEUKEMIA SOCIETY OF AMERICA IMMUNOTHERAPY OF LEUKEMIA & LYMPHOMA PRESS CONFERENCE FRIDAY, SEPTEMBER 25, 1998, 9:30 AM LIVE FROM THE NATIONAL PRESS CLUB, WASHINGTON, DC Reporters who are not able to attend may email questions to panelists "live" from the Web Site www.broadcast.com Leading scientists and cancer researchers from around the world will convene in Washington, DC for a two-day Symposium on Immunotherapy of Leukemia and Lymphoma co-sponsored by the Leukemia Society of America and Berlex Laboratories. Press Conference Agenda: Dwayne Howell, President & CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Leukemia Society of America: Opening remarks W. Stratford May, M.D., Ph.D, Chair, Leukemia Society of America Medical & Scientific Committee; Sealy Center for Oncology/Hematology, University of Texas Medical Branch "UTMB" redirects here. For other system schools, see University of Texas System. The University of Texas Medical Branch (UTMB) is a component of the University of Texas System located in Galveston, Texas, about 50 miles (80 km) southeast of downtown Houston. : Overview of immunotherapy Freda Stevenson, D. Phil, Southampton University Hospital Trust, UK: DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. vaccines against b-cell malignancies Irwin Bernstein, M.D., Leukemia Society of America Medical & Scientific Committee; Fred Hutchinson Cancer Research Center: Target therapy in acute myelogenous leukemia acute myelogenous leukemia n. Abbr. AML Myelogenous leukemia characterized by rapid abnormal increase in the number of myeloblasts and progression of symptoms. Peter J. Quesenberry, M.D., Leukemia Society of America Medical & Scientific Committee; University of Massachusetts The system includes UMass Amherst, UMass Boston, UMass Dartmouth (affiliated with Cape Cod Community College), UMass Lowell, and the UMass Medical School. It also has an online school called UMassOnline. Medical Center: Allochimeric models for cellular immune therapy |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion